Prescient Therapeutics Limited (PTX.AX)
AUD 0.05
(2.27%)
AUD 0.05
(2.27%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 2.32 Million AUD | 14.4% |
| 2023 | 2.03 Million AUD | 137.49% |
| 2022 | 856.01 Thousand AUD | 58.62% |
| 2021 | 539.67 Thousand AUD | -38.95% |
| 2020 | 883.95 Thousand AUD | 28.89% |
| 2019 | 685.79 Thousand AUD | 24.34% |
| 2018 | 551.56 Thousand AUD | 23.98% |
| 2017 | 444.89 Thousand AUD | -45.91% |
| 2016 | 822.55 Thousand AUD | 86.47% |
| 2015 | 441.12 Thousand AUD | 74.43% |
| 2014 | 252.89 Thousand AUD | 0.0% |
| 2013 | - AUD | -100.0% |
| 2012 | 1.84 Million AUD | 20.53% |
| 2011 | 1.53 Million AUD | 19.02% |
| 2010 | 1.28 Million AUD | -27.85% |
| 2009 | 1.78 Million AUD | 6.48% |
| 2008 | 1.67 Million AUD | 13.62% |
| 2007 | 1.47 Million AUD | -12.15% |
| 2006 | 1.68 Million AUD | 24.23% |
| 2005 | 1.35 Million AUD | 164.83% |
| 2004 | 510.81 Thousand AUD | -24.88% |
| 2003 | 680 Thousand AUD | 51.64% |
| 2002 | 448.42 Thousand AUD | -32.84% |
| 2001 | 667.73 Thousand AUD | 520.49% |
| 2000 | 107.61 Thousand AUD | -10.1% |
| 1999 | 119.7 Thousand AUD | 93.13% |
| 1998 | 61.97 Thousand AUD | -54.9% |
| 1997 | 137.42 Thousand AUD | 109.17% |
| 1996 | 65.7 Thousand AUD | -97.24% |
| 1995 | 2.38 Million AUD | -57.18% |
| 1994 | 5.56 Million AUD | 11.23% |
| 1993 | 5 Million AUD | -11.84% |
| 1992 | 5.67 Million AUD | 4.61% |
| 1991 | 5.42 Million AUD | 0.67% |
| 1990 | 5.38 Million AUD | -1.86% |
| 1989 | 5.49 Million AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q4 | 2.32 Million AUD | 0.0% |
| 2024 Q2 | 2.15 Million AUD | 0.0% |
| 2024 FY | 2.32 Million AUD | 14.4% |
| 2023 FY | 2.03 Million AUD | 137.49% |
| 2023 Q2 | 1.08 Million AUD | 0.0% |
| 2023 Q4 | 2.03 Million AUD | 0.0% |
| 2022 FY | 856.01 Thousand AUD | 58.62% |
| 2022 Q2 | 431.15 Thousand AUD | 0.0% |
| 2022 Q4 | 856.01 Thousand AUD | 0.0% |
| 2021 Q4 | 539.67 Thousand AUD | 0.0% |
| 2021 FY | 539.67 Thousand AUD | -38.95% |
| 2021 Q2 | 262.67 Thousand AUD | 0.0% |
| 2020 FY | 883.95 Thousand AUD | 28.89% |
| 2020 Q2 | 662.85 Thousand AUD | 0.0% |
| 2020 Q4 | 883.95 Thousand AUD | 0.0% |
| 2019 FY | 685.79 Thousand AUD | 24.34% |
| 2019 Q4 | 685.79 Thousand AUD | 0.0% |
| 2019 Q2 | 501.29 Thousand AUD | 0.0% |
| 2018 FY | 551.56 Thousand AUD | 23.98% |
| 2018 Q4 | 551.56 Thousand AUD | 0.0% |
| 2018 Q2 | 273.45 Thousand AUD | 0.0% |
| 2017 FY | 444.89 Thousand AUD | -45.91% |
| 2017 Q4 | 444.89 Thousand AUD | 0.0% |
| 2017 Q2 | 231.55 Thousand AUD | 0.0% |
| 2016 FY | 822.55 Thousand AUD | 86.47% |
| 2016 Q2 | 617.65 Thousand AUD | 0.0% |
| 2016 Q4 | 822.55 Thousand AUD | 0.0% |
| 2015 FY | 441.12 Thousand AUD | 74.43% |
| 2015 Q2 | 437.67 Thousand AUD | 0.0% |
| 2015 Q4 | 441.12 Thousand AUD | 0.0% |
| 2014 Q4 | 252.89 Thousand AUD | 0.0% |
| 2014 FY | 252.89 Thousand AUD | 0.0% |
| 2014 Q2 | 35 Thousand AUD | 0.0% |
| 2013 Q3 | - AUD | 0.0% |
| 2013 Q1 | - AUD | -100.0% |
| 2013 FY | - AUD | -100.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2012 FY | 1.84 Million AUD | 20.53% |
| 2012 Q4 | 1.84 Million AUD | 0.0% |
| 2011 FY | 1.53 Million AUD | 19.02% |
| 2011 Q4 | 1.53 Million AUD | 0.0% |
| 2010 FY | 1.28 Million AUD | -27.85% |
| 2010 Q4 | 1.28 Million AUD | 0.0% |
| 2009 Q4 | 1.78 Million AUD | 0.0% |
| 2009 FY | 1.78 Million AUD | 6.48% |
| 2008 FY | 1.67 Million AUD | 13.62% |
| 2008 Q4 | 1.67 Million AUD | 0.0% |
| 2007 FY | 1.47 Million AUD | -12.15% |
| 2007 Q4 | 1.47 Million AUD | 0.0% |
| 2006 Q4 | 1.68 Million AUD | 0.0% |
| 2006 FY | 1.68 Million AUD | 24.23% |
| 2005 FY | 1.35 Million AUD | 164.83% |
| 2005 Q4 | 1.35 Million AUD | 0.0% |
| 2004 Q4 | 510.81 Thousand AUD | 0.0% |
| 2004 FY | 510.81 Thousand AUD | -24.88% |
| 2003 FY | 680 Thousand AUD | 51.64% |
| 2003 Q4 | 680 Thousand AUD | 0.0% |
| 2002 FY | 448.42 Thousand AUD | -32.84% |
| 2002 Q4 | 448.42 Thousand AUD | 0.0% |
| 2001 FY | 667.73 Thousand AUD | 520.49% |
| 2001 Q4 | 667.73 Thousand AUD | 0.0% |
| 2000 Q4 | 107.61 Thousand AUD | 0.0% |
| 2000 FY | 107.61 Thousand AUD | -10.1% |
| 1999 Q4 | 119.7 Thousand AUD | 0.0% |
| 1999 FY | 119.7 Thousand AUD | 93.13% |
| 1998 FY | 61.97 Thousand AUD | -54.9% |
| 1997 FY | 137.42 Thousand AUD | 109.17% |
| 1997 Q4 | 137.42 Thousand AUD | 0.0% |
| 1996 FY | 65.7 Thousand AUD | -97.24% |
| 1995 FY | 2.38 Million AUD | -57.18% |
| 1994 FY | 5.56 Million AUD | 11.23% |
| 1993 FY | 5 Million AUD | -11.84% |
| 1992 FY | 5.67 Million AUD | 4.61% |
| 1991 FY | 5.42 Million AUD | 0.67% |
| 1990 FY | 5.38 Million AUD | -1.86% |
| 1989 FY | 5.49 Million AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Memphasys Limited | 5.59 Million AUD | 58.416% |
| Race Oncology Limited | 1.91 Million AUD | -21.349% |
| AdAlta Limited | 3.54 Million AUD | 34.354% |
| Anatara Lifesciences Ltd | 306.84 Thousand AUD | -657.885% |
| Bio-Gene Technology Limited | 368.44 Thousand AUD | -531.182% |
| BTC Health Limited | 203.94 Thousand AUD | -1040.273% |
| CSL Limited | 27.88 Billion AUD | 99.992% |
| Clarity Pharmaceuticals Ltd | 8.33 Million AUD | 72.088% |
| Cynata Therapeutics Limited | 1.17 Million AUD | -98.587% |
| Imugene Limited | 33.14 Million AUD | 92.983% |
| NeuroScientific Biopharmaceuticals Limited | 85.68 Thousand AUD | -2614.147% |
| PharmAust Limited | 896.6 Thousand AUD | -159.374% |
| Proteomics International Laboratories Limited | 1.62 Million AUD | -43.03% |
| Acrux Limited | 5.68 Million AUD | 59.107% |
| Botanix Pharmaceuticals Limited | 3.73 Million AUD | 37.687% |
| Clinuvel Pharmaceuticals Limited | 28.11 Million AUD | 91.728% |
| Island Pharmaceuticals Limited | 1.04 Million AUD | -122.409% |
| Nyrada Inc. | 855.63 Thousand AUD | -171.794% |
| Orthocell Limited | 22.08 Million AUD | 89.469% |
| Radiopharm Theranostics Limited | 44.68 Million AUD | 94.795% |
| Starpharma Holdings Limited | 8.69 Million AUD | 73.263% |
| Zelira Therapeutics Limited | 9.35 Million AUD | 75.145% |
| Arovella Therapeutics Limited | 2.05 Million AUD | -13.076% |
| Alterity Therapeutics Limited | 5.42 Million AUD | 57.138% |
| Amplia Therapeutics Limited | 3.42 Million AUD | 32.136% |
| Biome Australia Limited | 5.37 Million AUD | 56.72% |
| Biotron Limited | 737.5 Thousand AUD | -215.327% |
| Chimeric Therapeutics Limited | 12.8 Million AUD | 81.836% |
| EZZ Life Science Holdings Limited | 4.22 Million AUD | 45.011% |
| Immutep Limited | 10.97 Million AUD | 78.819% |
| Invex Therapeutics Ltd | 431.63 Thousand AUD | -438.786% |
| Noxopharm Limited | 1.28 Million AUD | -80.47% |
| Patrys Limited | 691.36 Thousand AUD | -236.373% |
| PYC Therapeutics Limited | 10.18 Million AUD | 77.165% |
| Telix Pharmaceuticals Limited | 249.39 Million AUD | 99.068% |
| Dimerix Limited | 13.89 Million AUD | 83.261% |
| Hexima Limited | 248.67 Thousand AUD | -835.2% |
| Neuren Pharmaceuticals Limited | 42.76 Million AUD | 94.562% |
| Nanollose Limited | 465.64 Thousand AUD | -399.43% |
| Tissue Repair Ltd | 1.35 Million AUD | -72.149% |
| AnteoTech Limited | 4.07 Million AUD | 42.935% |
| Paradigm Biopharmaceuticals Limited | 3.58 Million AUD | 35.119% |
| Recce Pharmaceuticals Ltd | 15.89 Million AUD | 85.368% |
| Avecho Biotechnology Limited | 941.54 Thousand AUD | -146.996% |
| Actinogen Medical Limited | 1.61 Million AUD | -43.965% |
| Immuron Limited | 2.84 Million AUD | 18.129% |
| Argenica Therapeutics Limited | 2.42 Million AUD | 4.168% |